• Discovery of biotech to support development the Innovative medicines and promotion of strategic joint investment by pharmaceutical companies in biotech
- (role of Gateway) Deal Sourcing Open Innovation, Establishment of a continuous and efficient discovery system for high-quality pipelines
- (role of priming water) Capital Open Innovation, Leading a system that can make continuous capital investment in excellent pipelines
- (role of platform) Development Open Innovation, Establishment of a flexible collaboration system that can supplement the necessary development capabilities
• Operation of KIMCo investment business
- Investment process : 1st Evaluation(written) ▷ 2nd Evaluation(IR Announcement) ▷ Review
- Investment Evaluation certeria : Evaluate the Market attractiveness ( scalability), Technology attractiveness (innovation/differentiation), Commercialization competitiveness (competitive advantage
- Investment schedule : Twice a year in the first half/second half
• Provision of investment plans for excellent biotech to participating companies, acceleration of practical collaboration between pharmaceutical companies and biotech
• Sharing future trends and insights through analysis of biopharmaceutical industry experts (technology, investment, etc.) and global industry data
※ KIMCo Talk(On·offline seminars), KIMCo Insight(Reports on the latest trends and issues related to technology, market, investment, etc.), KIMCo workshop etc
• Establishment of a collaboration platform and network that can complement each other's expertise required for new drug development and global commercialization
• Reinforcement of two-way communication with KIMCo-participating companies promotion of industry·university·government·pension·finance networking
• We have performed 'Project on developing TBM'(2021~2024) to support 7 pharmaceutical companies with a project cost of 13 billion won.
Promoting the global commercialization of TBM dominating the pharmerging market• Publication of a market and technology analysis report to support companies participating in specific tasks to advance into the pharmerging market
• licensing consulting support, and operation of industry-academia consultative groups ∙
• KIMCo carried out '2023 QbD system roll-out supporting project' to conduct QbD consultation and operate a training program for QbD experts
Improving drug quality, Increasing the efficiency of R&D and manufacturing process, and creating the competitiveness in the global market• Performed '2023 QbD system roll-out supporting project'
- [Consultation] Conducted at least 5 cases of customized consultation
- [Education] Operated training program for QbD experts
• KIMCo carried out '23 Smart Factory Setting Up Projects' for the sake of drug quality improvement
Increasing the efficiency of Manufacturing&Production&Quality Controls and the competitiveness of companies• To inspect and manage projects so that the projects can be completed successfully
• Ministry of Trade, Industry and Energy 'mRNA vaccine raw material production advancement technology development'project ('22~'25) Joint implementation of overall project, KRW 18.1 billion supported to 5 pharmaceutical companies
Success in localization of production of cGMP-level core mRNA vaccine raw materials and securing global competitiveness• mRNA vaccine raw material market/technology trend research, government/institutional/private (demand-supplier) consultative body operation, win-win cooperation between demand-supply companies and support for establishing an ecosystem for the vaccine industry, etc.